Topotecan

Topotecan is a high-purity Antineoplastic Agent supplied by Mediocon Inc as an Active Pharmaceutical Ingredient (API) conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India, it meets the stringent quality requirements of global pharmaceutical manufacturers.

Topotecan is a semisynthetic derivative of camptothecin and a topoisomerase I inhibitor used in oncology for the treatment of ovarian cancer, small cell lung cancer, and cervical cancer.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing facility

Applications

• Ovarian cancer (second-line treatment)
• Small cell lung cancer
• Cervical cancer
• Antineoplastic formulation development

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings